Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/21/2024

Janusmed kön och genus

Janusmed kön och genus – disulfiram

Janusmed kön och genus är ett kunskapsstöd som tillhandahåller information om köns- och genusaspekter på läkemedelsbehandling. Kunskapsstödet är avsedd främst för hälso- och sjukvårdspersonal. Texterna är generella och ska inte ses som behandlingsriktlinjer. Det är alltid behandlande läkare som ansvarar för patientens medicinering.

För att komma till startsidan för Janusmed kön och genus och för att göra sökningar klicka här.

Tillbaka till index
B B
B B

Disulfiram Testmiljö

Disulfiram

Klass : B

Visa all info

Skriv ut

Kontakta oss

  1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-60.

  2. Folkhälsan i Sverige Årsrapport 2014. Folkhalsomyndigheten [www]. [updated 2015-12-28, cited 2016-04-19].

  3. Helander A, Löwenmo C, Johansson M. Distribution of acetaldehyde in human blood: effects of ethanol and treatment with disulfiram. Alcohol Alcohol. 1993;28:461-8.

  4. ANTABUS (disulfiram). Summary of Product Characteristics. Medical Products Agency (MPA); 2016.

  5. Aguiar P, Neto D, Lambaz R, Chick J, Ferrinho P. Prognostic factors during outpatient treatment for alcohol dependence: cohort study with 6 months of treatment follow-up. Alcohol Alcohol. 2012;47:702-10.

  6. HOFF EC, MCKEOWN CE. An evaluation of the use of tetraethylthiuram disulfide in the treatment of 560 cases of alcohol addiction. Am J Psychiatry. 1953;109:670-3.

  7. Lundwall L, Baekeland F. Disulfiram treatment of alcoholism. J Nerv Ment Dis. 1971;153:381-94.

  8. Pani PP, Trogu E, Vacca R, Amato L, Vecchi S, Davoli M. Disulfiram for the treatment of cocaine dependence. Cochrane Database Syst Rev. 2010;1:CD007024.

  9. DISULFIRAM (disulfiram). DailyMed [www]. US National Library of Medicine. [updated 2012-08-31, cited 2016-03-31].

  10. DeVito EE, Babuscio TA, Nich C, Ball SA, Carroll KM. Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram. Drug Alcohol Depend. 2014;145:156-67.

  11. Nich C, McCance-Katz EF, Petrakis IL, Cubells JF, Rounsaville BJ, Carroll KM. Sex differences in cocaine-dependent individuals' response to disulfiram treatment. Addict Behav. 2004;29:1123-8.

  12. Fonsi Elbreder M, de Souza e Silva R, Pillon SC, Laranjeira R. Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment. Alcohol Alcohol. 2011;46:74-6.

  13. Harris AH, Kivlahan DR, Bowe T, Humphreys KN. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv. 2010;61:392-8.

  14. Socialstyrelsens statistikdatabas . Stockholm: Socialstyrelsen. 2014 [cited 2016-02-17.]

  1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-60.
  2. Folkhälsan i Sverige Årsrapport 2014. Folkhalsomyndigheten [www]. [updated 2015-12-28, cited 2016-04-19].
  3. Helander A, Löwenmo C, Johansson M. Distribution of acetaldehyde in human blood: effects of ethanol and treatment with disulfiram. Alcohol Alcohol. 1993;28:461-8.
  4. ANTABUS (disulfiram). Summary of Product Characteristics. Medical Products Agency (MPA); 2016.
  5. Aguiar P, Neto D, Lambaz R, Chick J, Ferrinho P. Prognostic factors during outpatient treatment for alcohol dependence: cohort study with 6 months of treatment follow-up. Alcohol Alcohol. 2012;47:702-10.
  6. HOFF EC, MCKEOWN CE. An evaluation of the use of tetraethylthiuram disulfide in the treatment of 560 cases of alcohol addiction. Am J Psychiatry. 1953;109:670-3.
  7. Lundwall L, Baekeland F. Disulfiram treatment of alcoholism. J Nerv Ment Dis. 1971;153:381-94.
  8. Pani PP, Trogu E, Vacca R, Amato L, Vecchi S, Davoli M. Disulfiram for the treatment of cocaine dependence. Cochrane Database Syst Rev. 2010;1:CD007024.
  9. DISULFIRAM (disulfiram). DailyMed [www]. US National Library of Medicine. [updated 2012-08-31, cited 2016-03-31].
  10. DeVito EE, Babuscio TA, Nich C, Ball SA, Carroll KM. Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram. Drug Alcohol Depend. 2014;145:156-67.
  11. Nich C, McCance-Katz EF, Petrakis IL, Cubells JF, Rounsaville BJ, Carroll KM. Sex differences in cocaine-dependent individuals' response to disulfiram treatment. Addict Behav. 2004;29:1123-8.
  12. Fonsi Elbreder M, de Souza e Silva R, Pillon SC, Laranjeira R. Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment. Alcohol Alcohol. 2011;46:74-6.
  13. Harris AH, Kivlahan DR, Bowe T, Humphreys KN. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv. 2010;61:392-8.
  14. Socialstyrelsens statistikdatabas . Stockholm: Socialstyrelsen. 2014 [cited 2016-02-17.]